First Trust Nasdaq Pharmaceuticals ETF (FTXH) Holdings → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free FTXH Stock Alerts $25.85 -0.37 (-1.41%) (As of 04/25/2024 ET) Add Compare Share Share HoldingsStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Top 50 FTXH HoldingsRankCompanyCurrent PriceWeightShares Held1MRKMerck & Co., Inc.$130.03+2.4%7.58%11,6722PFEPfizer$25.43-3.2%7.35%55,8773BMYBristol-Myers Squibb$44.59-8.7%7.32%29,2434ABBVAbbVie$166.95-0.5%7.19%8,4305JNJJohnson & Johnson$146.91-1.1%6.95%9,1966LLYEli Lilly and Company$725.02-1.0%3.81%985 Get the Latest News and Ratings for FTXH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 7AMGNAmgen$269.87-1.2%3.69%2,7108UTHRUnited Therapeutics$235.18-0.8%3.66%2,9809CAHCardinal Health$104.05+0.5%3.64%6,62710VRTXVertex Pharmaceuticals$398.97-0.4%3.60%1,76411REGNRegeneron Pharmaceuticals$893.43-1.4%3.56%76812GILDGilead Sciences$65.34-2.6%3.53%10,29213VTRSViatris$11.47-0.7%3.46%59,98814BIIBBiogen$202.36+0.2%3.38%3,42015JAZZJazz Pharmaceuticals$107.89-0.4%3.10%5,47616ZTSZoetis$153.04+1.4%2.97%3,74117OGNOrganon & Co.$18.29-2.2%2.72%29,37318CRLCharles River Laboratories International$227.16-5.1%2.05%1,74119PRGOPerrigo$31.27+0.1%1.47%9,50220MEDPMedpace$386.34-2.8%1.45%74621HALOHalozyme Therapeutics$38.53-1.5%1.26%6,41922INCYIncyte$51.03-1.4%0.98%3,57023ALKSAlkermes$24.39-1.1%0.96%7,75624EXELExelixis$23.59-0.5%0.94%8,08925NBIXNeurocrine Biosciences$136.67-1.7%0.88%1,28826PBHPrestige Consumer Healthcare$70.01-0.2%0.83%2,34127ELANElanco Animal Health$12.97-2.6%0.73%10,31728ILMNIllumina$120.43-2.0%0.60%99229EXASExact Sciences$59.13-6.5%0.59%1,80130BMRNBioMarin Pharmaceutical$83.67-8.3%0.56%1,20131ITCIIntra-Cellular Therapies$71.95-1.6%0.56%1,49132KRYSKrystal Biotech$155.47-2.3%0.55%65033ACLXArcellx$51.49-2.5%0.53%1,88534BPMCBlueprint Medicines$91.07-1.3%0.51%1,10835ROIVRoivant Sciences$10.86-0.4%0.49%9,05936SRPTSarepta Therapeutics$128.79+3.7%0.49%81037IONSIonis Pharmaceuticals$42.33-0.3%0.48%2,29238MLTXMoonLake Immunotherapeutics$42.04-0.9%0.47%2,14839RYTMRhythm Pharmaceuticals$38.46-3.1%0.47%2,38740IDYAIDEAYA Biosciences$39.20-1.6%0.45%2,319“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars).41MRUSMerus$44.95+7.1%0.45%2,13842RAREUltragenyx Pharmaceutical$43.26-2.3%0.45%2,00443VKTXViking Therapeutics$67.12+3.2%0.45%1,34544KYMRKymera Therapeutics$33.16-5.8%0.44%2,42745TGTXTG Therapeutics$13.79-1.4%0.44%6,01846ARVNArvinas$31.89-2.0%0.40%2,25447NUVLNuvalent$65.88-2.0%0.40%1,23248ACADACADIA Pharmaceuticals$16.31-1.7%0.39%4,45949CRSPCRISPR Therapeutics$53.37-4.1%0.36%1,23150BEAMBeam Therapeutics$21.58-5.1%0.33%2,624 Geographic ExposureUnited States92.5%Ireland5.5%Bermuda0.5%Cayman Islands0.5%Netherlands0.5%Switzerland0.3%Currency ExposureUSD91.7%Sector ExposureHealth Care94.4%Industry ExposureBiotechnology77.3%Pharmaceuticals5.2%Health Care Technology3.5%Health Care Providers & Services2.1%Diversified Consumer Services1.5%Health Care Equipment & Supplies1.2%SubIndustry ExposureBiotechnology76.5%Pharmaceuticals5.7%Health Care Distributors3.5%Life Sciences Tools & Services2.7%Health Care Services2.1% Related Companies and Tools Related Companies: Horizon Kinetics Medical ETF Portfolio Companies Invesco Nasdaq Biotechnology ETF Portfolio Companies JPMorgan Healthcare Leaders ETF Portfolio Companies ProShares UltraShort Nasdaq Biotechnology Portfolio Companies Principal Healthcare Innovators ETF Portfolio Companies ProShares Ultra Nasdaq Biotechnology Portfolio Companies Invesco Dorsey Wright Healthcare Momentum ETF Portfolio Companies Invesco S&P SmallCap Health Care ETF Portfolio Companies VanEck Biotech ETF Portfolio Companies VanEck Pharmaceutical ETF Portfolio Companies This page (NASDAQ:FTXH) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
